Emese Zsiros, MD, PhD, FACOG, spoke about the newly approved pembrolizumab regimen in PD-L1–expressing, pretreated platinum-resistant gynecologic cancers.
Emese Zsiros, MD, PhD, FACOG
Advertisement
Articles by Emese Zsiros, MD, PhD, FACOG
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CancerNetwork
1
Unmet Needs, Combination Therapies, and the Future of CAR T Consolidation in MCL
2
FDA Removes Black Box Warning for Breast Cancer and Other Indications on HRT Products
3
Advances in Immunotherapy for Breast Cancer
4
What Were the Key Abstracts and Presentations at The 2026 Tandem Meetings?
5